# Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients

> **NCT02461797** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 26 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **OTHER:** healthy controls
- **OTHER:** AR patients without medication
- **OTHER:** AR patients with use of nasal corticoid spray

## Key facts

- **NCT ID:** NCT02461797
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02461797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02461797, "Evaluation of Nasal Mucosal Permeability in Controls and House Dust Mite Allergic Rhinitis Patients". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02461797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*